| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8261374 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2012 | 9 Pages |
Abstract
âºLowering cholesterol reduces transporter-mediated glutamate release from nerve terminals. âºLowering cholesterol attenuates glutamate release by heteroexchange and in low N+ medium. âºLowering cholesterol decreases glutamate release during dissipation of the proton gradient of synaptic vesicles. âºLowering cholesterol may be used for neuroprotection after stroke, cerebral hypoxia/ischemia. âºA decrease in transporter-mediated glutamate release may be mechanism of neuroprotective effect of statins.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
N. Krisanova, R. Sivko, L. Kasatkina, T. Borisova,